Week 19: Settling Into 2.4mg
The third injection at the target dose. Side effects are usually quiet, appetite is steady, and the rhythm of life at 2.4mg is becoming familiar — less an adjustment phase, more a routine.
Week 19 is the third injection at 2.4mg and the middle of the first month at the target dose. By this point, almost everyone has fully adjusted. The injection day is routine, the appetite pattern is predictable, and the body has integrated the higher dose into its baseline. The drama of the titration phase is decisively over.
What this stretch reveals is what life at the target dose actually looks like — not the early flares, not the novelty of deeper suppression, just the steady picture of low appetite, easy meals, and gradual weight loss. That is the picture you will be working with for the long-term phase of the journey.
Appetite Suppression
Strong, consistent suppression. Most users describe meals as a scheduled task rather than a hunger-driven event.
Loss continues steadily for most users, though slower weeks become more common as cumulative loss grows.
The Week 19 Timeline
The Week 19 Timeline
Day 127 (Injection 19)
Third 2.4mg Dose
Routine injection. Adjustment effects are uncommon by the third shot at this dose.
Days 129-131
Steady Pattern
Appetite, energy, and digestion all follow a predictable rhythm by now. The dose has become invisible — just another part of the week.
Day 133
Habit Reinforcement
A good week to reinforce the small habits — protein at each meal, fluid intake, a daily walk — that determine how the long phase goes.
Navigating Symptoms
If side effects have been minimal through the first three weeks at 2.4mg, the rest of the maintenance period is likely to look similar. Any new symptom is worth flagging promptly.
The work this week is mostly invisible — the protein you put on the plate, the water you drink across the day, the walks that happen even when you do not feel like it. None of these will move the scale visibly on any single day. All of them protect the response over the long term, especially as appetite suppression makes under-eating a real risk.
It is also worth thinking about what success at the target dose looks like for you specifically. The trial data shows a wide range of outcomes — some people lose much more than the mean, some less, and the curve flattens for almost everyone. Defining "good enough" before the inevitable plateaus arrive makes them easier to navigate when they do.
What Users Report
“Week 19 felt like a quiet success. I'm not thinking about food much, I'm not feeling crappy, and the scale is moving slowly but consistently. That is the goal.”
— Tasha M.
“I had to actively work on getting enough protein this week. The appetite is so low that without planning, I would have eaten way too little.”
— Felix D.
Looking ahead
Week 20 is the fourth week at 2.4mg and closes out the first full month at the target dose. It is a natural moment to do a small review — how the dose feels, how the habits are holding, what the trend on the scale looks like. The pattern from this month tends to predict the next several.